What are the major opportunities in the Chronic Kidney Disease market? What are the strategies for the Chronic Kidney Disease market?

For detailed insights on the major opportunities and strategies in the Chronic Kidney Disease market, Read More

How does the Chronic Kidney Disease market relate to the overall economy and other similar markets?

For detailed insights on Chronic Kidney Disease's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Chronic Kidney Disease market growth? SWOT analysis of the Chronic Kidney Disease market.

For detailed insights on the key dynamics influencing the Chronic Kidney Disease market growth and SWOT analysis of the Chronic Kidney Disease industry, Read More

Chronic Kidney Disease Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Chronic Kidney Disease Market Report 2026

Name: Chronic Kidney Disease Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Diagnosis (Blood Test, Urine Test, Imaging Test, Kidney Biopsy), By Treatment (Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments), By Route of Administration (Oral, Intravenous, Subcutaneous), By End-User (Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Chronic Kidney Disease Market Overview

• Chronic Kidney Disease market size has reached to $74.87 billion in 2025

• Expected to grow to $101.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%

• Growth Driver: The Rising Prevalence Of Kidney Disease Drives Growth In The Chronic Kidney Disease Market

• Market Trend: Awak Technologies And Singapore General Hospital Forge Strategic Partnership To Revolutionize Kidney Dialysis With Awak Pd

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chronic Kidney Disease Market?

Chronic kidney disease is characterized by the inability of damaged kidneys to efficiently filter blood, resulting in excess fluid and blood waste in the body, potentially leading to health problems. It is commonly caused by diabetes, high blood pressure, and obesity. It requires careful, ongoing management and has the potential to proceed to end-stage renal failure requiring dialysis or transplant.

The main diagnostic tests for chronic kidney disease are blood tests, urine tests, imaging tests, and a kidney biopsy. A blood test refers to the scientific examination of a blood sample that will be examined medically. The various types of treatments include drugs, dialysis, kidney transplants, ACE inhibitors, blood tests, and others. These drugs are administered through oral, intravenous, and subcutaneous routes of administration, and are used by various end-users, such as hospitals and clinics, ambulatory surgery centers (ASCS), dialysis centers, and others.

Chronic Kidney Disease Market Global Report 2026 Market Report bar graph

What Is The Chronic Kidney Disease Market Size and Share 2026?

The chronic kidney disease market size has grown strongly in recent years. It will grow from $74.87 billion in 2025 to $79.43 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising prevalence of diabetes and hypertension, increased availability of dialysis infrastructure, improved kidney function diagnostics, growing awareness of chronic renal disorders, expansion of nephrology care services.

What Is The Chronic Kidney Disease Market Growth Forecast?

The chronic kidney disease market size is expected to see strong growth in the next few years. It will grow to $101.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing development of novel renal therapies, rising demand for patient-centric dialysis options, expansion of digital kidney health monitoring, growing focus on transplant readiness, increasing investments in preventive nephrology. Major trends in the forecast period include increasing emphasis on early ckd detection, rising adoption of renoprotective drug therapies, growing use of home dialysis solutions, expansion of multidisciplinary care models, enhanced focus on slowing disease progression.

Book your 30 minutes free consultation with our research experts

Global Chronic Kidney Disease Market Segmentation

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-Ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Is The Driver Of The Chronic Kidney Disease Market?

The increasing prevalence of kidney disease is expected to propel the growth of the chronic kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Medication for kidney disease is used to control blood pressure in patients and decrease protein loss to halt the progression of kidney impairment, manage symptoms, and avoid consequences. For instance, in June 2023, according to the Kidney Research UK, a UK-based, charity dedicated to funding research into kidney disease, by 2033, the population affected by CKD stages 3–5 is expected to rise to around 3.9 million. Therefore, the increasing prevalence of kidney disease is driving the growth of the chronic kidney disease industry.

Key Players In The Global Chronic Kidney Disease Market

Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Global Chronic Kidney Disease Market Trends and Insights

Major companies operating in the chronic kidney disease market are adopting a strategic partnership approach to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in June 2023, AWAK Technologies Pte Ltd., a Singapore-based medical technology company, partnered with Singapore General Hospital Pte Ltd. (SGH), a Singapore-based academic health science center and hospital company. With this partnership, they aim to revolutionize the diagnosis, treatment, and management of kidney disease and involve the development and testing of a wearable and ultra-portable peritoneal dialysis (PD) system, known as AWAK PD, which allows patients with end-stage kidney disease to undergo dialysis at home and on the go.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Chronic Kidney Disease Market?

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. The acquisition will add CinCor's candidate medicine, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure control in treatment-resistant hypertension, to AstraZeneca's cardiorenal pipeline. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company that develops products to treat resistant and uncontrolled hypertension and chronic kidney disease.

Regional Outlook

North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Kidney Disease Market?

The chronic kidney disease market consists of revenues earned by entities by providing peritoneal dialysis, in-center hemodialysis, and home hemodialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic kidney disease market also includes sales such as captopril, enalapril, finerenone, and fosinopril used during the treatment procedure. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Kidney Disease Market Report 2026?

The chronic kidney disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic kidney disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Chronic Kidney Disease Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$79.43 billion
Revenue Forecast In 2035	$101.87 billion
Growth Rate	CAGR of 6.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Diagnosis, Treatment, Route of Administration, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Chronic Kidney Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Chronic Kidney Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Chronic Kidney Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Chronic Kidney Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Emphasis On Early Ckd Detection

4.2.2 Rising Adoption Of Renoprotective Drug Therapies

4.2.3 Growing Use Of Home Dialysis Solutions

4.2.4 Expansion Of Multidisciplinary Care Models

4.2.5 Enhanced Focus On Slowing Disease Progression

5. Chronic Kidney Disease Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Dialysis Centers

5.3 Ambulatory Surgery Centers

5.4 Nephrology Clinics

5.5 Diagnostic Laboratories

6. Chronic Kidney Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Chronic Kidney Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Chronic Kidney Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Chronic Kidney Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Chronic Kidney Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Chronic Kidney Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Chronic Kidney Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Chronic Kidney Disease Market Segmentation

9.1. Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Blood Test, Urine Test, Imaging Test, Kidney Biopsy

9.2. Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

9.3. Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Subcutaneous

9.4. Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

9.5. Global Chronic Kidney Disease Market, Sub-Segmentation Of Blood Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

9.6. Global Chronic Kidney Disease Market, Sub-Segmentation Of Urine Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

9.7. Global Chronic Kidney Disease Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ultrasound, CT Scan, MRI, X-Ray

9.8. Global Chronic Kidney Disease Market, Sub-Segmentation Of Kidney Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

10. Chronic Kidney Disease Market Regional And Country Analysis

10.1. Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Chronic Kidney Disease Market

11.1. Asia-Pacific Chronic Kidney Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Chronic Kidney Disease Market

12.1. China Chronic Kidney Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Chronic Kidney Disease Market

13.1. India Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Chronic Kidney Disease Market

14.1. Japan Chronic Kidney Disease Market Overview

14.2. Japan Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Chronic Kidney Disease Market

15.1. Australia Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Chronic Kidney Disease Market

16.1. Indonesia Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Chronic Kidney Disease Market

17.1. South Korea Chronic Kidney Disease Market Overview

17.2. South Korea Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Chronic Kidney Disease Market

18.1. Taiwan Chronic Kidney Disease Market Overview

18.2. Taiwan Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Chronic Kidney Disease Market

19.1. South East Asia Chronic Kidney Disease Market Overview

19.2. South East Asia Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Chronic Kidney Disease Market

20.1. Western Europe Chronic Kidney Disease Market Overview

20.2. Western Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Chronic Kidney Disease Market

21.1. UK Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Chronic Kidney Disease Market

22.1. Germany Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Chronic Kidney Disease Market

23.1. France Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Chronic Kidney Disease Market

24.1. Italy Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Chronic Kidney Disease Market

25.1. Spain Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Chronic Kidney Disease Market

26.1. Eastern Europe Chronic Kidney Disease Market Overview

26.2. Eastern Europe Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Chronic Kidney Disease Market

27.1. Russia Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Chronic Kidney Disease Market

28.1. North America Chronic Kidney Disease Market Overview

28.2. North America Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Chronic Kidney Disease Market

29.1. USA Chronic Kidney Disease Market Overview

29.2. USA Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Chronic Kidney Disease Market

30.1. Canada Chronic Kidney Disease Market Overview

30.2. Canada Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Chronic Kidney Disease Market

31.1. South America Chronic Kidney Disease Market Overview

31.2. South America Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Chronic Kidney Disease Market

32.1. Brazil Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Chronic Kidney Disease Market

33.1. Middle East Chronic Kidney Disease Market Overview

33.2. Middle East Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Chronic Kidney Disease Market

34.1. Africa Chronic Kidney Disease Market Overview

34.2. Africa Chronic Kidney Disease Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Chronic Kidney Disease Market Regulatory and Investment Landscape

36. Chronic Kidney Disease Market Competitive Landscape And Company Profiles

36.1. Chronic Kidney Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Chronic Kidney Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Chronic Kidney Disease Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Chronic Kidney Disease Market Other Major And Innovative Companies

Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd

38. Global Chronic Kidney Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Chronic Kidney Disease Market

40. Chronic Kidney Disease Market High Potential Countries, Segments and Strategies

40.1 Chronic Kidney Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Chronic Kidney Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Chronic Kidney Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Chronic Kidney Disease Market, Overview Of Key Products - Product Examples

Table 2: Global Chronic Kidney Disease Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Chronic Kidney Disease Market, Supply Chain Analysis

Table 4: Global Chronic Kidney Disease Market, Major Raw Material Providers

Table 5: Global Chronic Kidney Disease Market, Major Resource Providers

Table 6: Global Chronic Kidney Disease Market, Major Manufacturers (Suppliers)

Table 7: Global Chronic Kidney Disease Market, Major Distributors And Channel Partners

Table 8: Global Chronic Kidney Disease Market, Key Technologies & Future Trends

Table 9: Global Chronic Kidney Disease Market, Major Trends

Table 10: Global Chronic Kidney Disease Market, Major End Users

Table 11: Global Chronic Kidney Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Chronic Kidney Disease Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Chronic Kidney Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Chronic Kidney Disease Market - TAM, US$ Billion, 2025

Table 15: Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Chronic Kidney Disease Market, Sub-Segmentation Of Blood Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Chronic Kidney Disease Market, Sub-Segmentation Of Urine Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Chronic Kidney Disease Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Chronic Kidney Disease Market, Sub-Segmentation Of Kidney Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Chronic Kidney Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Chronic Kidney Disease Market - Company Scoring Matrix

Table 99: Pfizer Inc Financial Performance

Table 100: Johnson and Johnson Services Inc. Financial Performance

Table 101: F. Hoffmann-La Roche Ltd. Financial Performance

Table 102: AbbVie Inc. Financial Performance

Table 103: Bayer AG Financial Performance

Table 104: Global Chronic Kidney Disease Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Chronic Kidney Disease Market, Competitive Dashboard

Table 106: Global Chronic Kidney Disease Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Chronic Kidney Disease Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 108: Global, Chronic Kidney Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 109: Global, Chronic Kidney Disease Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Chronic Kidney Disease Market, Overview Of Key Products - Product Examples

Figure 2: Global Chronic Kidney Disease Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Chronic Kidney Disease Market, Supply Chain Analysis

Figure 4: Global Chronic Kidney Disease Market, Major Raw Material Providers

Figure 5: Global Chronic Kidney Disease Market, Major Resource Providers

Figure 6: Global Chronic Kidney Disease Market, Major Manufacturers (Suppliers)

Figure 7: Global Chronic Kidney Disease Market, Major Distributors And Channel Partners

Figure 8: Global Chronic Kidney Disease Market, Key Technologies & Future Trends

Figure 9: Global Chronic Kidney Disease Market, Major Trends

Figure 10: Global Chronic Kidney Disease Market, Major End Users

Figure 11: Global Chronic Kidney Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Chronic Kidney Disease Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Chronic Kidney Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Chronic Kidney Disease Market - TAM, US$ Billion, 2025

Figure 15: Global Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Chronic Kidney Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Chronic Kidney Disease Market, Sub-Segmentation Of Blood Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Chronic Kidney Disease Market, Sub-Segmentation Of Urine Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Chronic Kidney Disease Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Chronic Kidney Disease Market, Sub-Segmentation Of Kidney Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Chronic Kidney Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Chronic Kidney Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Chronic Kidney Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Chronic Kidney Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Chronic Kidney Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Chronic Kidney Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Chronic Kidney Disease Market - Company Scoring Matrix

Figure 99: Pfizer Inc Financial Performance

Figure 100: Johnson and Johnson Services Inc. Financial Performance

Figure 101: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 102: AbbVie Inc. Financial Performance

Figure 103: Bayer AG Financial Performance

Figure 104: Global Chronic Kidney Disease Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Chronic Kidney Disease Market, Competitive Dashboard

Figure 106: Global Chronic Kidney Disease Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Chronic Kidney Disease Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 108: Global, Chronic Kidney Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 109: Global, Chronic Kidney Disease Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Kidney Disease Market Report 2026 - Global Outlook – By Treatment (Medication, Dialysis, Surgery, Other Treatments), By Indication (Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications)...

Diabetic Kidney Disease Market Report 2026 - Global Outlook – By Type (Type 1 Diabetes, Type 2 Diabetes), By Treatment (Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant In...

Late Stage Chronic Kidney Disease Drugs Market Report 2026 - Global Outlook – By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders), By Indication Type (Late Stage Chroni...

Rare Kidney Diseases Market Report 2026 - Global Outlook – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications...

Kidney Dialysis Market Report 2026 - Global Outlook – By Type (Hemodialysis, Peritoneal Dialysis), By Product And Service (Equipment, Consumables, Dialysis Drugs, Services), By End-User (Home Care, Dialysis Centers And H...

Continuous Renal Replacement Therapy Market Report 2026 - Global Outlook – By Product (System, Consumables), By Therapy (Renal, Non-Renal), By Modality (Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemo...

Renal Biomarkers Market Report 2026 - Global Outlook – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced ...

Frequently Asked Questions

How big is the Chronic Kidney Disease Market?

The Chronic Kidney Disease market was valued at $74.87 billion in 2025, increased to $79.43 billion in 2026, and is projected to reach $101.87 billion by 2030. request a sample here

What is the Chronic Kidney Disease market growth?

The global Chronic Kidney Disease market is expected to grow at a CAGR of 6.4% from 2026 to 2035 to reach $101.87 billion by 2035. request a sample here

Who are the key players in Chronic Kidney Disease market?

Some Key Players in the Chronic Kidney Disease market Include, Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp . request a sample here

What is the anticipated growth trend for the Chronic Kidney Disease market?

Major trend in this market includes: Awak Technologies And Singapore General Hospital Forge Strategic Partnership To Revolutionize Kidney Dialysis With Awak Pd. For further insights on this market. request a sample here

Which region has the most growth potential in the Chronic Kidney Disease market?

North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Chronic Kidney Disease Market Report 2026 market?

Major companies operating in the Chronic Kidney Disease Market Report 2026 market are Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp request a sample here.

Which region has the most growth potential in the Chronic Kidney Disease Market Report 2026 market?